Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma

BACKGROUND: The TP53 gene is estimated to be mutated in over 50% of tumors, with the majority of tumors exhibiting abnormal TP53 signaling pathways. However, the exploration of TP53 mutation-related LncRNAs in Hepatocellular carcinoma (HCC) remains incomplete. This study aims to identify such LncRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Chenghao, Liu, Daoli, Wang, Duofa, Hu, Shuangjiu, Zhang, Yongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637161/
https://www.ncbi.nlm.nih.gov/pubmed/37942552
http://dx.doi.org/10.1177/03946320231211795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637161/
https://www.ncbi.nlm.nih.gov/pubmed/37942552
http://dx.doi.org/10.1177/03946320231211795

Ejemplares similares